Carl Hull - 16 Jan 2024 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Executive Chairman, Director
Signature
/s/ Kurt Oreshack, by power of attorney for Carl Hull
Issuer symbol
MRVI
Transactions as of
16 Jan 2024
Net transactions value
$0
Form type
4
Filing time
18 Jan 2024, 18:23:32 UTC
Previous filing
17 Mar 2023
Next filing
20 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award +75,842 +35% 295,361 16 Jan 2024 Direct F1
holding MRVI Class A Common Stock 35,000 16 Jan 2024 Through Glossatori, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in one-half (1/2) increments on each of January 15, 2025, and January 15, 2026, subject to the Reporting Person's continued employment with the Issuer.

Remarks:

Executive Chairman